SNPX: Synaptogenix, Inc. Stock

by  •  • Comments Off on SNPX: Synaptogenix, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 5.14
Enterprise Value ($M) -22.28
Book Value ($M) 25.58
Book Value / Share 23.57
Price / Book 0.20
NCAV ($M) 25.00
NCAV / Share 23.04
Price / NCAV 0.21

Profitability (mra)
Return on Invested Capital (ROIC) -0.24
Return on Assets (ROA) -0.17
Return on Equity (ROE) -0.18

Liquidity (mrq)
Quick Ratio 7.14
Current Ratio 7.14

Balance Sheet (mrq) ($M)
Current Assets 30.53
Assets 31.11
Liabilities 5.53
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -8.31
Net Income -6.04
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -5.17
Cash from Investing -2.00
Cash from Financing -1.64

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-06 13G/A Intracoastal Capital, Llc 4.99 33.24

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 46,721 161,783 28.88
2024-05-02 14,440 47,339 30.50
2024-05-01 13,755 47,558 28.92
2024-04-30 77,285 18,967 407.47
2024-04-29 997 5,921 16.84

(click for more detail)

Similar Companies
SNDL – SNDL Inc. SNGX – Soligenix, Inc.
SNOA – Sonoma Pharmaceuticals, Inc. SNTI – Senti Biosciences, Inc.
SONN – Sonnet BioTherapeutics Holdings, Inc.


Financial data and stock pages provided by
Fintel.io